AbbVie's Deal with Apogee; Regenxbio Moves on Gene Therapy Drug | Stock Movers
BloombergDuração: 3:41
Ler a matéria completaA seguir
- Isomorphic Labs Seeks Funding at Valuation of $40 Billion
- EU Striking Harder Line on China's Trade Gap
- Why Investors Are Skeptical Over Australian Data Center Company Firmus's IPO
- What to Know About Suspected Plague Case in Siberia
- Saudi-Led Forces Claim Ground Advances Against Houthis in Yemen
- Micron Rallies as AI Tailwinds Drive a Street-High Price Target | Closing Bell
